Repertoire of P-glycoprotein drug transporters in the zoonotic nematode Toxocara canis.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
27 03 2023
27 03 2023
Historique:
received:
18
11
2022
accepted:
14
03
2023
medline:
29
3
2023
entrez:
27
3
2023
pubmed:
28
3
2023
Statut:
epublish
Résumé
Toxocara canis has a complex lifecycle including larval stages in the somatic tissue of dogs that tolerate macrocyclic lactones. In this study, we investigated T. canis permeability glycoproteins (P-gps, ABCB1) with a putative role in drug tolerance. Motility experiments demonstrated that while ivermectin failed to abrogate larval movement, the combination of ivermectin and the P-gp inhibitor verapamil induced larval paralysis. Whole organism assays revealed functional P-gp activity in larvae which were capable of effluxing the P-gp substrate Hoechst 33342 (H33342). Further investigation of H33342 efflux demonstrated a unique rank order of potency for known mammalian P-gp inhibitors, suggesting that one or more of the T. canis transporters has nematode-specific pharmacological properties. Analysis of the T. canis draft genome resulted in the identification of 13 annotated P-gp genes, enabling revision of predicted gene names and identification of putative paralogs. Quantitative PCR was used to measure P-gp mRNA expression in adult worms, hatched larvae, and somatic larvae. At least 10 of the predicted genes were expressed in adults and hatched larvae, and at least 8 were expressed in somatic larvae. However, treatment of larvae with macrocyclic lactones failed to significantly increase P-gp expression as measured by qPCR. Further studies are needed to understand the role of individual P-gps with possible contributions to macrocyclic lactone tolerance in T. canis.
Identifiants
pubmed: 36973306
doi: 10.1038/s41598-023-31556-1
pii: 10.1038/s41598-023-31556-1
pmc: PMC10042841
doi:
Substances chimiques
Ivermectin
70288-86-7
ATP Binding Cassette Transporter, Subfamily B
0
Lactones
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
4971Subventions
Organisme : NIAID NIH HHS
ID : R21 AI144493
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI163790
Pays : United States
Informations de copyright
© 2023. The Author(s).
Références
Int J Parasitol. 2016 Sep;46(10):631-40
pubmed: 27172882
Br Vet J. 1983 Nov-Dec;139(6):471-5
pubmed: 6652454
J Am Vet Med Assoc. 1983 Nov 1;183(9):987-90
pubmed: 12002591
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
Vet Parasitol. 2013 Jan 31;191(3-4):264-75
pubmed: 23062691
Int J Parasitol. 1994 May;24(3):321-6
pubmed: 8070948
Res Vet Sci. 1984 Jan;36(1):87-91
pubmed: 6546805
Exp Parasitol. 2017 Oct;181:70-74
pubmed: 28760359
Int J Parasitol Drugs Drug Resist. 2016 Aug;6(2):103-15
pubmed: 27164439
Eur J Pharm Sci. 2007 Jan;30(1):84-94
pubmed: 17134887
Int J Parasitol Drugs Drug Resist. 2021 Dec;17:191-203
pubmed: 34753107
Mol Biol Evol. 2018 Jun 1;35(6):1547-1549
pubmed: 29722887
Vet Parasitol. 2011 Feb 10;175(3-4):382-5
pubmed: 21074327
Trends Parasitol. 2017 Jun;33(6):463-472
pubmed: 28285851
Am J Trop Med Hyg. 2004 Nov;71(5):608-16
pubmed: 15569793
Mol Biol Evol. 2008 Jul;25(7):1307-20
pubmed: 18367465
Int J Parasitol. 1991 Nov;21(7):771-6
pubmed: 1774112
Nat Commun. 2015 Feb 04;6:6145
pubmed: 25649139
Int J Parasitol Drugs Drug Resist. 2014 Aug 28;4(3):233-43
pubmed: 25516834
Eur J Biochem. 1999 Feb;259(3):841-50
pubmed: 10092872
Crit Rev Microbiol. 1997;23(3):233-51
pubmed: 9347222
PLoS Pathog. 2015 Apr 07;11(4):e1004781
pubmed: 25849454
Parasit Vectors. 2016 Jan 28;9:52
pubmed: 26822677
Vet Parasitol. 2014 Nov 15;206(1-2):38-42
pubmed: 24594213
Vet Parasitol. 2011 Feb 10;175(3-4):193-206
pubmed: 21095061
Parasitol Res. 2018 Feb;117(2):365-370
pubmed: 29264719
Trends Parasitol. 2010 Jul;26(7):334-40
pubmed: 20478743
Parasit Vectors. 2012 Dec 07;5:288
pubmed: 23216873
Eur J Biochem. 1997 Nov 15;250(1):115-21
pubmed: 9431998
Am J Vet Res. 1987 Feb;48(2):281-3
pubmed: 3826867
Vet Parasitol. 1998 Jan 31;74(2-4):243-59
pubmed: 9561710
Exp Parasitol. 1993 Aug;77(1):88-96
pubmed: 8344410
PLoS One. 2020 Aug 6;15(8):e0237150
pubmed: 32760111
Chem Biol Interact. 2006 Feb 25;159(3):169-79
pubmed: 16384552
Mol Biol Evol. 2017 Sep 1;34(9):2422-2424
pubmed: 28472384
J Vet Med B Infect Dis Vet Public Health. 2006 Jun;53(5):218-23
pubmed: 16732879
Int J Parasitol. 2015 Jan;45(1):85-93
pubmed: 25486495
Sci Rep. 2020 Aug 12;10(1):13586
pubmed: 32788636
Vet Parasitol. 1999 Sep 1;85(4):305-12
pubmed: 10488732
Int J Parasitol Drugs Drug Resist. 2014 Jul 12;4(3):143-51
pubmed: 25516824
Vet Parasitol. 2014 Oct 15;205(3-4):638-45
pubmed: 25178553
Syst Biol. 2010 May;59(3):307-21
pubmed: 20525638
Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):20120-5
pubmed: 21041637
PLoS Pathog. 2018 May 2;14(5):e1006996
pubmed: 29719008
Neurosci Lett. 2003 Mar 13;339(1):62-6
pubmed: 12618301